ARTICLE | Clinical News
PharmaMar starts liver cancer Phase II
May 30, 2003 7:00 AM UTC
PharmaMar (Madrid, Spain) began a Phase II trial of its Kahalalide F to treat advanced liver cancer. The compound is derived from a sea slug and alters the function of the lysosomal membrane, the comp...